Podcasts about individualize

AUA2025: Non-Muscle Invasive Bladder Cancer Treatment Dilemmas: The Cases You Face and How Best to Treat Them CME Available: https://auau.auanet.org/node/43041 At the conclusion of this activity, participants will be able to: 1. Confidently apply updated guidelines to the care of patients with non-muscle-invasive bladder cancer. 2. Risk-stratify patients with non muscle- invasive bladder cancer. 3. Adapt treatment choices depending on risk of disease, including consideration to the availability of bacillus Calmette-Guérin. 4. Counsel and manage patients with bacillus Calmette-Guérin-unresponsive non muscle-invasive bladder cancer, including treatment selection with newly approved agents for BCG-unresponsive disease. 5. Individualize patient surveillance according to risk stratification. 6. Evaluate available urinary bladder cancer biomarkers and where to potentially utilize them in practice to inform management. ACKNOWLEDGEMENTS This educational activity is supported by an independent educational grants from: Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Please visit answersincme.com/860/95483855-replay2 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in oncology discuss antibody-drug conjugates in HER2-low advanced breast cancer, including current guideline recommendations and evolving treatment considerations to optimize individualized care. Upon completion of this activity, participants should be better able to: Review guideline-concordant approaches to individualize treatment selection for patients with HER2-low and -ultralow advanced breast cancer; and Outline evidence-based strategies to enhance the management of patients with HER2-low and -ultralow advanced breast cancer.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZWD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 12, 2026.Securing Equity in Care and Outcomes for Older Patients With HR+, HER2- MBC: Leveraging Patient Assessment, Clinical Evidence, Real-World Experience, and Shared Decision-Making to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZWD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 12, 2026.Securing Equity in Care and Outcomes for Older Patients With HR+, HER2- MBC: Leveraging Patient Assessment, Clinical Evidence, Real-World Experience, and Shared Decision-Making to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZWD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 12, 2026.Securing Equity in Care and Outcomes for Older Patients With HR+, HER2- MBC: Leveraging Patient Assessment, Clinical Evidence, Real-World Experience, and Shared Decision-Making to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZWD865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until March 12, 2026.Securing Equity in Care and Outcomes for Older Patients With HR+, HER2- MBC: Leveraging Patient Assessment, Clinical Evidence, Real-World Experience, and Shared Decision-Making to Individualize Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Living Beyond Breast Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZPG865. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and GRASP. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZPG865. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and GRASP. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZPG865. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and GRASP. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZPG865. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and GRASP. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

Balancing personalization and automation in donor stewardship is a challenge every nonprofit faces. In this episode, Randall dives into the critical question of how to effectively engage donors at all levels—ensuring major donors feel valued while nurturing smaller donors with potential. He explores practical tactics for segmenting, automating, and personalizing stewardship efforts, from data-driven donor screening to leveraging volunteers for thank-you calls. The key takeaway? Thoughtful stewardship isn't just about efficiency—it's about strategically building relationships that elevate giving over time.

The prospect of markedly raising chemotherapy response rates and extending patient survival has been held out by scientists reporting a new AI-powered digital tool to optimize cancer management for individual patients. The tool creates a “digital twin” for each patient that makes it possible to predict response to specific treatment regimens and confidently predict outcomes, according to findings from a study reported by scientists at the EORTC-NCI-AACR 2024 Molecular Targets and Cancer Therapeutics Symposium.

For anyone who has been paying attention, you may already know that the takeaways related to hormone replacement therapy (HRT) from the original Women's Health Initiative (WHI) study have been completely overhauled. It's about time! As a result, it's not an understatement to say that we are in the midst of a total transformation in hormone replacement therapy (HRT) and it's essential that as providers we (1) get up to speed on the nuances of the new interpretations and (2) learn how to personalize the guidance we give. Dr. Allison Smith, from Precision Analytical, is really a bright, guiding light in this new era of hormone care. She joins me in this episode of New Frontiers to start to unpack some of those important considerations and share resources for where practitioners can learn more. She explains why more detailed hormone metabolite testing can provide answers to hormonal symptoms when standard serum measures of testosterone and estrogen are “normal.” She also shines a light on the need for understanding how our patients are metabolizing hormones, especially if they are on HRT as well as to optimize their long-term cardiovascular, bone, skin, and brain health. This is indispensable listening and I'm sure you'll enjoy this conversation as much as I did. - DrKF Check out the show notes at https://www.drkarafitzgerald.com/fxmed-podcast/ for the full list of links and resources. GUEST DETAILS Dr. Allison Smith, ND, Lead Clinical Educator at Precision Analytical Email drsmith@dutchtest.com Dr. Allison Smith completed her N.D. at the National University of Natural Medicine in Portland, Oregon, and has worked in private practice focusing on primary care, women's health and dermatologic laser therapy. Over the last 10 years, she has consulted with providers on thousands of cases in the context of hormone testing and brought awareness of testing to providers in clinical practice through consulting, webinars, case presentations, and articles. She now leads an esteemed lineup of clinical educators at Precision Analytical, home of the DUTCH test. THANKS TO OUR SPONSOR Precision Analytical, Home of the DUTCH Test https://dutchtest.com/ New Frontiers Listeners, elevate your patient care - download the A Sample Report of the DUTCH Test https://tinyurl.com/yc7e3xfh CONNECT WITH DrKF Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Group Program: https://tinyurl.com/4hvusavw Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

Today on the Run Culture podcast I chat to renowned exercise physiologist and running coach; Greg McMillan. We specifically talk about the importance of individualizing training. Over the years Greg has used a simple evaluation to help thousands of runners train more effectively, avoid injury and peak when it counts! He shares how you can do this too!Here are three questions every runner should answer:-How do I respond to certain training? Runners respond differently to different types of workouts and mileage. Are you a speedster, endurance monster or a combo runner?-How do I recover from certain training? Recovery isn't static. What workouts do you recover quickly from, what workouts do you take longer to recover from?-How do I adapt to certain training? What workouts give you a quick fitness boost (fast-adapting), what workouts take a bit longer (slow-adapting)?Greg McMillan is a renowned running coach, exercise physiologist and founder of McMillan Running. Greg has had some incredible mentors, including; Arthur Lydiard, Joe Vigil, David Martin, Gabriel Rosa and Jack Daniels. For a number of years Greg coached an Adidas sponsored pro team in Flagstaff, Arizona called 'McMillan Elite' or 'Team USA Arizona'. As you will see Greg has been a student of the sport his whole life, he is an incredible wealth of running knowledge and I am so grateful that he could share some of this with us today! If you want to learn more about; Greg's coaching services, try his world famous pacing calculator or just continue to be well informed about running, be sure to go to; www.mcmillanrunning.com

Bispecific antibodies represent a much-needed option for diverse patients with relapsed/refractory multiple myeloma (RRMM). This podcast activity will highlight key clinical trial evidence leading to approval of bispecific antibodies and will provide guidance on safely incorporating these agents into RRMM treatment paradigms. Clinical case scenarios will also be discussed to optimize and sequence bispecific antibodies to enable improved outcomes among distinct patient subsets.Launch Date: October 3 2024Release Date: October 3, 2024Expiration Date: September 30, 2025FACULTYJoseph Mikhael, MD, MEd, FRCPC, FACPProfessor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer CenterChief Medical Officer, International Myeloma FoundationConsultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research InstituteAdjunct Professor, College of Health Solutions, Arizona State UniversityCaitlin Costello, MDClinical Professor of MedicineDirector, Multiple Myeloma ProgramDivision of Blood and Marrow TransplantationMoores Cancer CenterUC San DiegoThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/relapsedrefractory-multiple-myeloma-podcast-series-clinical-viewpoints-to-individualize-bispecific-antibody-therapy

Bispecific antibodies represent a much-needed option for diverse patients with relapsed/refractory multiple myeloma (RRMM). This podcast activity will highlight key clinical trial evidence leading to approval of bispecific antibodies and will provide guidance on safely incorporating these agents into RRMM treatment paradigms. Clinical case scenarios will also be discussed to optimize and sequence bispecific antibodies to enable improved outcomes among distinct patient subsets.Launch Date: October 1, 2024Release Date: October 1, 2024Expiration Date: September 30, 2025FACULTYJoseph Mikhael, MD, MEd, FRCPC, FACPProfessor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer CenterChief Medical Officer, International Myeloma FoundationConsultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research InstituteAdjunct Professor, College of Health Solutions, Arizona State UniversityCaitlin Costello, MDClinical Professor of MedicineDirector, Multiple Myeloma ProgramDivision of Blood and Marrow TransplantationMoores Cancer CenterUC San DiegoThis podcast provides accredited continuing education credits.  To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast.https://www.practicepointcme.com/CMEHome/relapsedrefractory-multiple-myeloma-podcast-series-clinical-viewpoints-to-individualize-bispecific-antibody-therapy

In this conversation, Kumiko interviews Danielle Remigio about grief and loss, sharing their personal experiences of losing their parents and the challenges they faced. Inspired by Danielle's TEDx talk, 'Cleaning Up the Grief Process,' they discuss grief clutter and the importance of creating space for grief.The conversation highlights the need for open communication, empathy, and support when dealing with grief. They explore acknowledging and accepting grief, the role of support from loved ones, unexpected emotions, and the impact of milestones. They also offer advice for those navigating the grieving process.  IMPACTUFL QUOTES"I need to not stay silent and try to bottle it all up because other people don't know how to react." "Grief is not something that is linear"EPISODE CHAPTERS>>00:00 Introduction and Personal Stories of Loss>> 06:58 Cleaning Up the Grief Process: Navigating Loss and Grief>> 14:01 Understanding Grief Clutter: Emotional and Practical Burdens>> 21:00 Navigating the Complexities of Grief>> 25:49 The Importance of Support and Validation>> 29:00 Unexpected Emotions and the Anger Phase>> 32:07 The Impact of Milestones and Reminders>> 35:12 Evolving Perspectives on Grief>> 38:16 Advice for Navigating the Grieving Process ABOUT DANIELLE Danielle Remigio (she|her) is a Boston, MA based higher education administrator with a background in psychology, crisis response, and college student development.After losing both her parents within 18 months in 2016/17, she turned her personal focus to understanding her own grief and created a TEDxTalk called CLEANing Up the Grief Process to help others understand their grief and how to help others through difficult times. Her professional motto is "Analyze, Individualize, Empathize". Through empathy, intentionality, and a good plan, we can help one another through the darkness. DANIELLE'S LINKS & RESOURCESTo connect with Danielle, follow her at @dl_remigio on Instagram or https://www.linkedin.com/in/dlynremigio/ for information on how to work with her for training, speaking, or writing engagements. About Kumiko:Kumiko Love is the creator of The Budget Mom, LLC, a national bestselling author of the book "My Money My Way," and an Accredited Financial Counselor.She is a dedicated mom of two boys, a passionate sourdough baker, and the proud owner of Pine Manor Naturals. With over 2 million followers across social media, Kumiko's expertise and approachable style have been featured in major media outlets such as Forbes, The New York Times, and Good Morning America. As the host of The Miko Love Podcast, Kumiko dives into the exploration of her own passions and a range of captivating topics, offering fresh perspectives and engaging discussions about life. She inspires millions to take control of their financial lives while embracing passionate living and life fulfillment. Thank you for being a part of our community! Contact The Miko Love Podcast Follow me on Instagram @mikolovepodcast Email me at kumiko@mikolovepodcast.com Thanks for listening & keep feeding your curiosity!

This Five Minute Friday covers how to individualize programming within a sports team. These are here to answer the questions you may have about player development. Send your questions in here: https://forms.gle/9xwbFFFqgS5DT2Ec9 100 Player Development Tips: https://beyond-the-field-player-development.ck.page/09c6129dc1 Player Development Workshop: https://forms.gle/hjH2a7kR6cxEdK989 About Ed Jones II Who? Ed Jones. Ed is a player development nerd who served in the player development role for University of Houston, University of Kansas, and Baylor University football teams rising to the role of assistant athletic director. Ed has now since transitioned into the role of founder and CEO of Beyond The Field, where he helps impactful people create player development plans. In addition to being the founder of Beyond The Field, Ed is a two-time author, speaker, creator of The Player Development Pod, The Player Development Conference, The Player Development Newsletter, and the Beginners Guide to Player Development Course. Ed has also facilitated multiple Player Development Guide cohorts. Connect with Ed here: https://www.linkedin.com/in/edjonesii/ - Purchase 2024 Player Development Conference Replay: https://buy.stripe.com/fZe8wX0Ts0I23NS6or Player Development Cohort: https://forms.gle/JnnxqjDuFvpaq5gY6 Need help with Player Development Plan: https://forms.gle/ex5pbvF3U5g3e2zt9 PLEASE LIKE, SUBSCRIBE, AND SHARE. Let's Talk Player Development. Email me here: info@btfprogram.com Visit: https://www.btfprogram.com/ Follow: Twitter - https://twitter.com/BTF_Program Instagram - https://www.instagram.com/btf_program/ Facebook - https://www.facebook.com/BTFProgram COACHING Player Development Coaching Program: https://forms.gle/Z5Q1gepZAorzcHSe9 CONTENT The Player Development Newsletter: https://beyondthefield.substack.com Player Development Guide eBook: https://www.btfprogram.com/btf-program-resources/btf-ebook Head Coaches Guide to Player Development eBook: https://beyond-the-field-player-development.ck.page/products/beyond-the-field-the 100 PLAYER DEVELOPMENT TIPS: https://beyond-the-field-player-development.ck.page/09c6129dc1 COURSES Player Development Courses: https://btfplayerdevelopmentcourses.thinkific.com/collections

In this episode of the Critical Oxygen Podcast, Dr. Kat Campbell and I discuss running volume, training load, and the importance of individualization in training. We discuss concepts of training volume, training load, progression, and the impact of intensity on running performance. We also talk about the use of acute to chronic workload ratio, the role of duration versus mileage, and the importance of understanding individual athlete needs and stressors. We also emphasize the need for a conservative approach to training, the role of RPE in guiding effort, and the challenges of ego and mindset in training. The discussion also touches on the philosophy of training, the importance of easy runs, and the impact of training load on long-term health and performance. More about Kat: Kat (otherwise known as Runwithkat_dpt on Instagram) is a physical therapist that specializes in working with runners as well as a certified running coach, and Certified NASM personal trainer. Kat strives to make a difference in runners' lives by helping runners achieve goals they didn't think was once possible while keeping them healthy in the process. Kat believes in utilizing an individualized and holistic approach when working with runners. She is passionate about sharing her love for running to inspire others to feel confident to take on new challenges. Enjoying these podcasts? Subscribe to get notified when new episodes are released. If you have a question or topic you want us to address, leave a comment! Follow Phil on Instagram - https://www.instagram.com/criticalo2 Follow Laura on Instagram - https://www.instagram.com/runwithkat_dpt/ Check out her podcast - https://open.spotify.com/show/6uxvbNu8EvCacL5GFNqAzV?si=c53c6841b1ee4e52 Interested in learning more (courses, education, testing, etc)? Check out the critical oxygen website - https://www.criticaloxygen.com/ TAKEAWAYS 1) When individualizing training consider factors such as accumulated time on the feet, personal goals, past history, and other areas of life stress. 2) Using acute to chronic workload ratio can help to predict the chance of injury and promote adaptation. 3) For runners, a conservative approach to training, focusing on easy runs and recovery, is essential for long-term health and performance. With limited higher intensity work. 4) RPE (Rate of Perceived Exertion) is a valuable tool for guiding effort and ensuring appropriate training intensity. CHAPTERS 00:00 Introduction to Running Volume and Training Load 09:56 Understanding Training Volume and Load Management 15:10 The Role of Acute to Chronic Workload Ratio 29:40 The Importance of Individualized Training 40:16 The Role of RPE and Recovery in Training 47:17 Challenges of Ego and Mindset in Training 53:24 Philosophy of Training: Easy Runs and Long-Term Health 56:46 Managing Training Load and Volume for Success KEYWORDS running volume, training load, individualization, progression, intensity, acute to chronic workload ratio, duration, mileage, client needs, stressors, individualized training, volume, intensity, recovery, adaptation, conservative approach, RPE, ego, mindset, easy runs, training load, long-term health, performance

Shepherd leaders need to be in the pastures where God has placed them, faithfully caring for the sheep under their care, and individualizing that care for each and every sheep. Check out the video of my conversation with Karl Vaters.  You can check out more clips from this Church Lobby interview here. Check out my book Shepherd Leadership for yourself or for a pastor that you love. And also check out my latest book When Sheep Bite, which I think of as the prequel to Shepherd Leadership. ►► Would you please prayerfully consider supporting this ministry? My Patreon supporters get behind-the-scenes access to exclusive materials. ◀︎◀︎  

In episode #499 of the Pacey Performance Podcast, Rob is joined by guests Enda King, Ed Gannon, and Steve Short to delve into the intricacies of preventing and managing groin injuries. They emphasize the importance of monitoring and managing training loads, particularly during transitions from pre-season to in-season phases. The discussion highlights the need for regular assessments of range of motion, neuromuscular status, and strength, coupled with close communication with athletic training staff and massage therapists. The conversation covers how groin injuries often stem from asymmetries, stressing the necessity of identifying and managing these imbalances. This includes assessing load, function, and tissue tolerance during rehabilitation, and recognizing that asymmetry can vary by sport and individual. The guests also address the identification of high-risk players and the early warning signs of groin pain. They discuss strategies for mitigating risk, such as investigating markers like range of motion and hip strength, and implementing conservative training loads and reactivation exercises. Effective rehabilitation involves focusing on hip and trunk control, monitoring activities that provoke injury, and following a structured five-phase strategy for adductor strains. Furthermore, the podcast touches on the importance of individualized rehabilitation, taking into account each athlete's specific deficits and symptoms. They discuss the utility of various testing and monitoring methods, including unilateral long lever assessments and cutting assessments, to identify and address the root causes of groin injuries. In summary, the podcast underscores the necessity of a comprehensive approach involving regular monitoring, individualized rehabilitation strategies, and effective communication among all stakeholders to effectively prevent and manage groin injuries in ice hockey players. Main talking points: Assess range of motion and strength regularly. Identify and manage athlete asymmetries. Assess load, function, and tissue tolerance. Focus on hip and trunk control. Use a five-phase rehab strategy.Individualize rehabilitation for specific deficits. Utilize long lever assessments. Monitor activities provoking groin injuries.

This episode discusses the importance of embracing personal style through an individualized approach to style systems; encouraging individuals to understand and personalize style principles to express their true selves authentically. It emphasizes self-discovery, individualization, and connection with personal style goals, warning against homogenization and depersonalization in fashion. It encourages listeners to build a style toolbox, observe, experiment, and evolve their style in a meaningful and intentional way.Full Show Notes Ep 10

In this episode, Emil reveals his approach to game design. Then we move quickly into the ways to individualize sessions to each learner, including some principles of session design. Overall, Emil keeps the generic conditioning exercises out of skill training. Strength and conditioning is something you can do on your own time with coaches specialized to that. In Muay Thai class, you come to practice Muay Thai. Lastly, Emil and I discuss the injury landscape now that he's ecological. --- If you're new to the show, please sign up to the Combat Learning Newsletter at https://⁠combatlearning.com/newsletter⁠. I'll send you cheat sheets on how to transform your drills into maximum skill-building games and get you up to speed on the science of motor skill learning for martial arts. Plus, you'll never miss a show. Go to ⁠combatlearning.com/newsletter⁠ to get those resources now. --- Where to Find Emil...Instagram: ⁠https://www.instagram.com/bara.emil/⁠ --- Produced by Micah Peacock Intro Theme by Micah Peacock Outro Music is Synergy by Juche

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YHX865. CME/NCPD/CPE/AAPA/IPCE credit will be available until December 12, 2024.Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program has been supported by an independent educational grant from Gilead Sciences, Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerProfessor Chloe Orkin has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Grant/Research Support from Gilead Sciences, Inc. and ViiV Healthcare group of companies.Speaker for Gilead Sciences, Inc.; GSK; Merck Sharp & Dohme; and ViiV Healthcare group of companies.Patient Advocate/PlannerShawnte' Spriggs has no financial interests/relationships or affiliations in relation to this activity.Patient Advocate/PlannerDonald Young has no financial interests/relationships or affiliations in relation to this activity.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Ever wondered how a simple shift in daily habits could transform your energy levels and productivity? Join me as we unravel the secrets to optimizing health and performance in this insightful podcast episode. In this conversation, I sat down with a seasoned entrepreneur, Nick, who shared his journey of integrating health practices into his busy life. The dialogue touched upon various aspects, from morning routines to nutrition hacks and supplement choices. Nick emphasized the impact of a strategic diet, intermittent fasting, and the incorporation of specific supplements, revealing how these changes significantly enhanced his energy, focus, and overall well-being. We talked about the Million Dollar Body approach, emphasizing a low-carb diet and prioritizing protein intake for sustained energy, and underscored the importance of individualizing health practices, focusing on what works for you rather than adhering to generic advice. Moreover, it highlighted the value of strategic supplement choices in optimizing energy and performance throughout the day. The overarching lesson is the profound impact small, consistent lifestyle changes can have on one's health and productivity. Key Takeaways: Prioritize a strategic morning routine, including personalized supplement choices. Embrace a low-carb, high-protein diet for sustained energy and focus. Individualize health practices for a sustainable and enjoyable lifestyle. Resources: Million Dollar Body approach: milliondollarbodylabs.com FASTAID http://drinkforfasting.com Early Bird Cocktail: Nootropic supplement: https://www.amazon.com/-/es/stores/ClubEarlyBird/page/4FDC5B03-FC86-4292-9C7B-691EF38F5C44?ref_=ast_bln Athletic Greens: https://www.amazon.com/Athletic-Greens-Supplement-Multivitamin-Antioxidant/dp/B00THEPSPW Organifi Reds: Superfood blend with antioxidants: https://www.amazon.com/Organifi-Red-Juice-Pre-Workout-Performance/dp/B07NB4YB4N "The Million Dollar Body Method" by Nate Palmer: http://getnatesbook.com  

Go online to PeerView.com/UBM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease, with a mortality rate estimated to be about three times greater than that experienced by individuals of similar age without HCM. So far, the FDA has approved only one noninvasive treatment option indicated for the treatment of HCM—a first-in-class cardiac myosin inhibitor (CMI) called mavacamten. A second CMI, aficamten, is currently being studied. As timely diagnosis of patients with HCM may reduce or delay the need for invasive treatment, these treatment options are essential for cardiologists to understand. This PeerView activity covers what you need to know about diagnosing and managing HCM for optimal patient care. A patient case threads through each section and offers a window into real-world diagnostic and treatment challenges as our expert shares guidance and the latest evidence. By the end of this activity, you will be able to explain the underlying pathophysiology of HCM, apply your new knowledge for timely diagnosis and individualized treatment of HCM, and implement strategies for long-term patient safety and improved outcomes. Upon completion of this activity, participants should be better able to: Apply current guidance and the latest evidence to support accurate differential diagnosis and encourage early treatment in patients suspected of having HCM; Evaluate the efficacy and safety evidence supporting the ability of modern targeted strategies to address the underlying pathophysiology of HCM; Individualize treatment of HCM based on patients' personal preferences and goals of care and identify opportunities to reduce inequities; and Implement strategies that encourage and support regular assessment of clinical status, LVEF, and LVOT gradient in patients with HCM, consulting with specialty colleagues as needed.

Go online to PeerView.com/UBM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease, with a mortality rate estimated to be about three times greater than that experienced by individuals of similar age without HCM. So far, the FDA has approved only one noninvasive treatment option indicated for the treatment of HCM—a first-in-class cardiac myosin inhibitor (CMI) called mavacamten. A second CMI, aficamten, is currently being studied. As timely diagnosis of patients with HCM may reduce or delay the need for invasive treatment, these treatment options are essential for cardiologists to understand. This PeerView activity covers what you need to know about diagnosing and managing HCM for optimal patient care. A patient case threads through each section and offers a window into real-world diagnostic and treatment challenges as our expert shares guidance and the latest evidence. By the end of this activity, you will be able to explain the underlying pathophysiology of HCM, apply your new knowledge for timely diagnosis and individualized treatment of HCM, and implement strategies for long-term patient safety and improved outcomes. Upon completion of this activity, participants should be better able to: Apply current guidance and the latest evidence to support accurate differential diagnosis and encourage early treatment in patients suspected of having HCM; Evaluate the efficacy and safety evidence supporting the ability of modern targeted strategies to address the underlying pathophysiology of HCM; Individualize treatment of HCM based on patients' personal preferences and goals of care and identify opportunities to reduce inequities; and Implement strategies that encourage and support regular assessment of clinical status, LVEF, and LVOT gradient in patients with HCM, consulting with specialty colleagues as needed.

Go online to PeerView.com/UBM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease, with a mortality rate estimated to be about three times greater than that experienced by individuals of similar age without HCM. So far, the FDA has approved only one noninvasive treatment option indicated for the treatment of HCM—a first-in-class cardiac myosin inhibitor (CMI) called mavacamten. A second CMI, aficamten, is currently being studied. As timely diagnosis of patients with HCM may reduce or delay the need for invasive treatment, these treatment options are essential for cardiologists to understand. This PeerView activity covers what you need to know about diagnosing and managing HCM for optimal patient care. A patient case threads through each section and offers a window into real-world diagnostic and treatment challenges as our expert shares guidance and the latest evidence. By the end of this activity, you will be able to explain the underlying pathophysiology of HCM, apply your new knowledge for timely diagnosis and individualized treatment of HCM, and implement strategies for long-term patient safety and improved outcomes. Upon completion of this activity, participants should be better able to: Apply current guidance and the latest evidence to support accurate differential diagnosis and encourage early treatment in patients suspected of having HCM; Evaluate the efficacy and safety evidence supporting the ability of modern targeted strategies to address the underlying pathophysiology of HCM; Individualize treatment of HCM based on patients' personal preferences and goals of care and identify opportunities to reduce inequities; and Implement strategies that encourage and support regular assessment of clinical status, LVEF, and LVOT gradient in patients with HCM, consulting with specialty colleagues as needed.

Go online to PeerView.com/UBM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease, with a mortality rate estimated to be about three times greater than that experienced by individuals of similar age without HCM. So far, the FDA has approved only one noninvasive treatment option indicated for the treatment of HCM—a first-in-class cardiac myosin inhibitor (CMI) called mavacamten. A second CMI, aficamten, is currently being studied. As timely diagnosis of patients with HCM may reduce or delay the need for invasive treatment, these treatment options are essential for cardiologists to understand. This PeerView activity covers what you need to know about diagnosing and managing HCM for optimal patient care. A patient case threads through each section and offers a window into real-world diagnostic and treatment challenges as our expert shares guidance and the latest evidence. By the end of this activity, you will be able to explain the underlying pathophysiology of HCM, apply your new knowledge for timely diagnosis and individualized treatment of HCM, and implement strategies for long-term patient safety and improved outcomes. Upon completion of this activity, participants should be better able to: Apply current guidance and the latest evidence to support accurate differential diagnosis and encourage early treatment in patients suspected of having HCM; Evaluate the efficacy and safety evidence supporting the ability of modern targeted strategies to address the underlying pathophysiology of HCM; Individualize treatment of HCM based on patients' personal preferences and goals of care and identify opportunities to reduce inequities; and Implement strategies that encourage and support regular assessment of clinical status, LVEF, and LVOT gradient in patients with HCM, consulting with specialty colleagues as needed.

Today, I am blessed to have here with me Cynthia Thurlow. Cynthia Thurlow is a nurse practitioner, nutrition, and intermittent fasting expert, and two-time TEDx speaker. She is deeply committed to assisting women in achieving well-being via the healing power of nutrition and fasting. Cynthia believes that you may feel better tomorrow than you do now and wants to empower you to do so! Cynthia spent nearly 20 years in clinical medicine, working in both the emergency room and cardiology. Cynthia began to think more about the root causes of chronic health concerns, despite her appreciation for mainstream medicine's ability to treat disease and save lives. She quickly saw the importance of the connection between food and her patients' health. Cynthia pursued additional nutrition and functional testing training to help others achieve maximum health. This episode takes a deep dive into protein, mTor vs autophagy, biochemical individuality and more. / / E P I S O D E   S P ON S O R S  Wild Pastures: $20 OFF per Box for Life + Free Shipping for Life + $15 OFF your 1st Box! https://wildpastures.com/promos/save-20-for-life-lf?oid=6&affid=132&source_id=podcast&sub1=ad BonCharge: Blue light Blocking Glasses, Red Light Therapy, Sauna Blankets & More. Visit https://boncharge.com/pages/ketokamp and use the coupon code KETOKAMP for 15% off your order.  Text me the words "Podcast" +1 (786) 364-5002 to be added to my contacts list. [14:00] What's the Importance of Protein to Aging and Metabolic Health? ●      Protein is a critical macronutrient, especially as we age, as it helps stimulate muscle protein synthesis and maintain lean muscle tissue. ●      Contrary to previous beliefs, older individuals need more protein to combat muscle loss and support insulin sensitivity. ●      The minimum recommended protein intake per meal is 30 grams for most people, with some individuals requiring more based on their needs. ●      Properly understanding portion sizes and macronutrient combinations is essential for optimizing protein intake. ●      Inadequate protein consumption may contribute to the metabolic health crisis, emphasizing the importance of including enough protein in one's diet as they age. [18:06] Change Your Perspective and Support Your Overall Health! ●      Cancer is a multifactorial disease influenced by various factors, including diet, lifestyle, environmental exposures, and even emotional health. ●      Fixating on a single aspect, such as excess protein intake and mTOR activation, oversimplifies the complex nature of cancer development. ●      Chronic and habitual one-meal-a-day (OMAD) fasting can lead to metabolic distress, muscle loss, and hinder metabolic health. ●      Individuals must shift away from restrictive dieting and nourish their bodies with adequate nutrition to support overall health. ●      Society's disordered relationship with food, body image, and weight contributes to unhealthy dietary and lifestyle practices and the rise of unhealthy diet culture. [29:35] Here's What You Need To Know About Animal and Plant-Based Protein ●      The amino acid composition of animal-based protein is superior to that of plant-based protein. ●      When choosing plant-based protein, it's essential to be cautious about consuming excessive carbohydrates to meet protein intake goals. ●      Metabolic health and insulin sensitivity are significant in determining the ability to handle plant-based protein, particularly for those in perimenopause and menopause. ●      The Protein Leverage Hypothesis highlights the importance of adequate protein intake for satiety and blood sugar regulation. ●      Starting the day with a higher protein meal can lead to greater satiety and reduced cravings throughout the day, promoting healthier eating habits. [35:25] How Do You Get More Protein while Intermittent Fasting? Check this out! ●      Adjust your fasting and feeding windows to make it more manageable to consume an adequate amount of protein. ●      Slowly increase protein intake to reach your target, especially if you are metabolically healthy. ●      Use tracking apps like Chronometer to get a clear picture of your daily protein intake. ●      Consider incorporating a high-quality protein shake or amino acids if you struggle to meet your protein goals through whole foods. ●      Bio-individuality plays a significant role in choosing protein sources and added ingredients, so find what works best for your digestion and preferences. [46:14] Fasting for Menopausal Women and Its Benefits and Considerations ●      Focus on managing stress and improving sleep before diving into fasting for postmenopausal women. ●      Fasting should be considered one of many strategies and should not be added without addressing foundational issues like sleep and stress. ●      Individualize fasting strategies for postmenopausal women and use them as a beneficial stressor rather than overloading the body. ●      Hormone replacement therapy (HRT) is a valid option for menopausal women but should be approached with informed decision-making and working with healthcare providers. ●      Understand the hormonal changes in the body during menopause and their influence on fasting and health, including estrogen, progesterone, and testosterone. [56:08] Strategic Application of Stressors: Hormesis and Fasting ●      Utilize hormetic stressors like fasting, exercise, and cold exposure to promote resilience and strength. ●      Be strategic with stressors by understanding genetic susceptibility and personal tolerances. ●      For some, long fasting, categorized as more than 24 hours, may not be suitable, especially for lean middle-aged individuals, due to concerns about muscle loss. ●      Consider gender-specific and age-specific factors when determining the best fasting regimens. ●      Monitor health markers, including muscle mass and immune system function, to make informed decisions about fasting strategies. [1:02:00] Achieving Autophagy and Hormetic Stress ●      While eating breakfast can be challenging for some, the goal is to consume most of your daily calories earlier, optimizing cortisol levels and insulin sensitivity. ●      The timing of meals affects the body's balance of hormones like ghrelin and leptin. ●      Blue light exposure, especially at night, can disrupt hormonal rhythms and affect hunger hormones. ●      Scientific studies may vary in their findings regarding hormone levels, but real-world results and individual experiences should guide your eating schedule. ●      Monitoring your feelings, energy levels, weight loss, mood, and sleep quality is crucial in determining the right breakfast timing. [1:09:00] What effects on your health do environmental toxins have? Reduce Your Risk! ●      HRV (Heart Rate Variability) varies significantly from person to person due to genetic and individual factors, making it crucial to establish a personal baseline and progress over time. ●      Comparing your HRV to others can lead to frustration and unrealistic expectations, as it's heavily influenced by age, genetics, and other factors. ●      Environmental factors, such as mold exposure and EMF radiation, can profoundly affect health, leading to symptoms like poor sleep, weight gain, and inflammation. ●      Sensitivity to environmental stressors differs among individuals, making some more like "canaries in the coal mine" who react strongly to these exposures. ●      Identifying and addressing environmental contributors to health issues is vital to a holistic approach to well-being.   AND MUCH MORE!   Resources from this episode: ●      Website: https://cynthiathurlow.com/ ●      Intermittent Fasting Transformation: https://cynthiathurlow.com/book/ ●      Follow Cynthia ○      Facebook: https://www.facebook.com/CHTWellness/ ○      YouTube: https://www.youtube.com/cynthiathurlow ○      TikTok: https://www.tiktok.com/@cynthia_thurlow_ ○      Instagram: https://www.instagram.com/cynthia_thurlow_/ ●      Join the Keto Kamp Academy: https://ketokampacademy.com/7-day-trial-a ●      Watch Keto Kamp on YouTube: https://www.youtube.com/channel/UCUh_MOM621MvpW_HLtfkLyQ / / E P I S O D E   S P ON S O R S  Wild Pastures: $20 OFF per Box for Life + Free Shipping for Life + $15 OFF your 1st Box! https://wildpastures.com/promos/save-20-for-life-lf?oid=6&affid=132&source_id=podcast&sub1=ad BonCharge: Blue light Blocking Glasses, Red Light Therapy, Sauna Blankets & More. Visit https://boncharge.com/pages/ketokamp and use the coupon code KETOKAMP for 15% off your order.  Text me the words "Podcast" +1 (786) 364-5002 to be added to my contacts list. // F O L L O W ▸ instagram | @thebenazadi | http://bit.ly/2B1NXKW ▸ facebook | /thebenazadi | http://bit.ly/2BVvvW6 ▸ twitter | @thebenazadi http://bit.ly/2USE0so ▸clubhouse | @thebenazadi Disclaimer: This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast including Ben Azadi disclaim responsibility from any possible adverse effects from the use of information contained herein. Opinions of guests are their own, and this podcast does not accept responsibility of statements made by guests. This podcast does not make any representations or warranties about guests qualifications or credibility. Individuals on this podcast may have a direct or non-direct interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.  

Richard is a seven-figure earning coach, mentor, author, and speaker. He produces thought leadership on the conditions for optimizing human performance derived from research areas such as performance psychology, neuroscience, happiness economics and investor resilience and applies it to human beings obsessed with results such as entrepreneurs, workplace leaders, global brands and investors. He has applied ‘performance-based thinking' to over twelve publications on subjects such as wealth, branding, business, leadership, personal and professional success, life and motivation.   In this episode, Brad and Rich discuss how to set yourself apart from others and build success for yourself.   28:40 Rich University is FREE on his website. 50:00 This show deserves to be mainstream. 56:56 There's a game worth playing in where you find your real self and your real value.   Follow Richard @Richard.Dolan  Learn more about Richard https://RichardDolan.com  Watch the full video episode on Brad's Rumble here: https://rumble.com/c/c-2544182  Watch the full video episode on Brad's Youtube Here: https://bradlea.tv 

During this episode, Heathar Shepard, classical homeopath, author of The Sunlight Rx, chef and homesteader, talks about how to created individualized health plans using sunlight and food. Heathar shares her concerns with fad diets and with treating disease diagnosis and emphasizes the importance of instead, treating symptoms. Heathar discusses her concerns with the modern day approach to healing, why it's unhelpful and how it leads to a merry-go-round of unhelpful, cookie cutter health and diet protocols. And, how to individualize your healing protocols using food, sunlight and homeopathy to improve long-term health outcomes and support overall longevity and vitality.

The most effective music lesson experience is a triangle approach: Student Teacher Parent All working together for the success of those music lessons. But we worry about overbearing parents, or the other end of the spectrum, parents not communicating much at all. These 3 tips I share with you will help bring some practicality to the philosophy: 1. Set up clear expectations 2. Communicate clearly throughout 3. Individualize communication....a bit Share with others on the instagram post angelatoone_ what has worked for you and your studio! It's almost time for the "how I teach scales masterclass," next Tuesday September 19th! If you weren't fully taught the connection between scales and chords (I wasn't) then come see the secrets decoded before your eyes! And of course, actionable ways to teach these to your students. The very next week masterclass "chord secrets decoded" Watch how rote teaching of scales leads right into chords, which leads right into USING those chords however we want! I've had students go on to schoool jazz bands, other instruments, arranging, composing, or just playing any song they want with chord symbols only! Would hate for you to miss out on a chance to come live, but the replay will be available too! scales and chords decoded masterclass bundle

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/managing-tardive-dyskinesia-9045Featuring faculty Gregory Mattingly, MD, moderated by Gregg Sherman, MD.SummaryBesides identification of patients with Tardive Dyskinesia (TD), management options have not always provided much, if any, relief. Traditional approaches to managing TD were not only questionable, and some were potentially harmful, but the availability of newer medications has ushered in a new era in TD management. In this activity, discuss management principles and review two cases to put TD management into practice.This podcast was recorded and is being used with permission of the presenters.Learning ObjectiveUpon completion of this activity, learners should be able to:Individualize the management of TD using evidence-based strategies that target uncontrolled movementsThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).Summary of Individual DisclosuresAngela Golden has disclosed the following financial relationships:Consultant: SetPoint (obesity), WW (obesity)Advisor: Currax (obesity), Genesis (obesity), Lilly (obesity), Novo Nordisk (obesity), Acela (hypothyroidism)Speaker: Currax (obesity), Novo Nordisk (obesity)Receipt of Royalty: Amazon (fiction books), Springer (obesity book)Greg Mattingly has disclosed the following financial relationship:Consultant: AbbVie, Alkermes, Axsome, Biogen, Corium, Eisai, Ironshore, Intra-Cellular, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Redax, Roche, Sage, Sirona, Sunovion, Supernus, Takeda, TevaSpeaker: AbbVie, Alkermes, Axsome, Corium, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine Biosciences, Noven, Otsuka, Sunovion, Supernus, Takeda, Tris PharmaContracted Research: AbbVie, Alkermes, Akili, Axsome, Boehringer Ingelheim, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, Neurocrine Biosciences, NLS Pharmaceuticals, Otsuka, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, TevaAll his disclosures are related to mental healthFaculty, planners, guest patient(s) (if applicable), and moderators for this educational activity not listed in the Summary of Individual Disclosures above have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.Disclosure of Commercial Support This activity is supported by an independent medical education grant from Neurocrine Biosciences, Inc.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Go online to PeerView.com/EEG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Multiple professional societies have emphasized the importance of lowering LDL-C for the primary and secondary prevention of ASCVD and cardiovascular events. Though current guidelines recommend statins as the cornerstone of lipid-lowering therapies, many patients have insufficient response or intolerance to them and require non-statin therapies to achieve their individualized LDL-C goals. Enter PCSK9-targeting therapies! This CME activity shares current gaps in hyperlipidemia care, offers strategies for meeting these unmet needs, and presents the latest clinical data for PCSK9-targeting agents. An in-depth patient case example helps to illustrate the importance of screening and ASCVD risk assessment, how to initiate therapy with novel strategies, and best practices for improving hyperlipidemia management to help more patients achieve their goals. Upon completion of this activity, participants should be better able to: Incorporate evidence-based, guideline-compliant strategies into the management of hyperlipidemia to prevent primary and secondary cardiovascular events, especially in patients who are statin intolerant or already using the maximally tolerated statin dosage; Recognize the differences among PCSK9-targeting agents and other classes of lipid-lowering therapies for managing hyperlipidemia in individuals at high risk of ASCVD with regard to mechanisms of action, cardiovascular outcomes, and the latest clinical evidence; and Individualize treatment regimens to reduce cardiovascular events in high-risk patients with hyperlipidemia consistent with consensus recommendations and recent clinical evidence available for PCSK9-targeting therapies.

Go online to PeerView.com/EEG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Multiple professional societies have emphasized the importance of lowering LDL-C for the primary and secondary prevention of ASCVD and cardiovascular events. Though current guidelines recommend statins as the cornerstone of lipid-lowering therapies, many patients have insufficient response or intolerance to them and require non-statin therapies to achieve their individualized LDL-C goals. Enter PCSK9-targeting therapies! This CME activity shares current gaps in hyperlipidemia care, offers strategies for meeting these unmet needs, and presents the latest clinical data for PCSK9-targeting agents. An in-depth patient case example helps to illustrate the importance of screening and ASCVD risk assessment, how to initiate therapy with novel strategies, and best practices for improving hyperlipidemia management to help more patients achieve their goals. Upon completion of this activity, participants should be better able to: Incorporate evidence-based, guideline-compliant strategies into the management of hyperlipidemia to prevent primary and secondary cardiovascular events, especially in patients who are statin intolerant or already using the maximally tolerated statin dosage; Recognize the differences among PCSK9-targeting agents and other classes of lipid-lowering therapies for managing hyperlipidemia in individuals at high risk of ASCVD with regard to mechanisms of action, cardiovascular outcomes, and the latest clinical evidence; and Individualize treatment regimens to reduce cardiovascular events in high-risk patients with hyperlipidemia consistent with consensus recommendations and recent clinical evidence available for PCSK9-targeting therapies.

Go online to PeerView.com/EEG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Multiple professional societies have emphasized the importance of lowering LDL-C for the primary and secondary prevention of ASCVD and cardiovascular events. Though current guidelines recommend statins as the cornerstone of lipid-lowering therapies, many patients have insufficient response or intolerance to them and require non-statin therapies to achieve their individualized LDL-C goals. Enter PCSK9-targeting therapies! This CME activity shares current gaps in hyperlipidemia care, offers strategies for meeting these unmet needs, and presents the latest clinical data for PCSK9-targeting agents. An in-depth patient case example helps to illustrate the importance of screening and ASCVD risk assessment, how to initiate therapy with novel strategies, and best practices for improving hyperlipidemia management to help more patients achieve their goals. Upon completion of this activity, participants should be better able to: Incorporate evidence-based, guideline-compliant strategies into the management of hyperlipidemia to prevent primary and secondary cardiovascular events, especially in patients who are statin intolerant or already using the maximally tolerated statin dosage; Recognize the differences among PCSK9-targeting agents and other classes of lipid-lowering therapies for managing hyperlipidemia in individuals at high risk of ASCVD with regard to mechanisms of action, cardiovascular outcomes, and the latest clinical evidence; and Individualize treatment regimens to reduce cardiovascular events in high-risk patients with hyperlipidemia consistent with consensus recommendations and recent clinical evidence available for PCSK9-targeting therapies.

Jon England on supporting the changes in the education marketplace

Go online to PeerView.com/JHE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Recent research and improved understanding of the pathogenesis of multiple sclerosis (MS) has led to the development of multiple biomarkers and imaging modalities that can improve clinicians' ability to individualize therapy through more effective monitoring of disease progression and treatment response. The promise of eventually arriving at data-driven personalized care—coupled with the number of available and emerging therapies for MS treatment—makes it more important than ever that clinicians remain up-to-date on advances in biomarkers and imaging approaches, as well as shared decision-making strategies. In this activity, based on a recent live symposium, MS experts cover the latest data on these new and emerging biomarkers for MS management. Using examples from their own practice, the panelists also discuss ways to incorporate these biomarker findings into individualized treatment decisions to empower patients and improve treatment outcomes. Upon completion of this activity, participants should be better able to: Describe emerging biomarkers that may play a role in evaluating MS disease activity, progression, and treatment response; Individualize treatment decisions for patients with MS, incorporating biomarker findings, disease status, and other patient-specific characteristics; and Integrate team-based shared decision-making strategies to facilitate appropriate treatment selection, empower patients, and improve outcomes

Ever feel like the typical parenting strategies don't work for your family?  Chances are good that you have at least one kid who is a little differently wired. **** True Presence Podcast Announcement: August Webinar:  SIMPLIFY YOUR SCHOOL YEAR.  Save your Seat.  *** This wonderful interview with Ginny Kochis of Not So Formulaic is about embracing our kids' individuality and finding the tools we need to parent them for the way God made them. Want to know more about Ginny's amazing resources?  Check them out here!. In this episode, Ginny shares her personal journey and experiences as a Catholic mom raising neurodiverse kids. She talks about the challenges she faced when her first child was diagnosed with autism and how that led her to start a ministry for differently wired families. Ginny emphasizes the importance of accepting and embracing the uniqueness of each child while also building executive function skills to help them navigate daily tasks. Ginny offers valuable insights into parenting differently wired kids, highlighting the need for moms to take care of themselves and find respite care. She advocates for cultivating an appreciation for the mysterious in faith and focusing on mercy and grace when approaching faith formation. Ginny draws inspiration from the life of St. Zelie Martin, who faced her own struggles with anxiety and depression, making her a relatable figure for moms on this roller coaster journey of parenting. If you're a Catholic mom raising neurodiverse kids and looking for support and resources, join Ginny's Facebook group, where you'll find a supportive community of like-minded parents. Check out her blog for free information on various aspects of parenting differently wired kids, and explore her paid resources, including workbooks, masterclasses, and family toolkits for handling anxiety and fostering growth mindset. Whether you're a Catholic mom or just interested in learning more about parenting neurodiverse kids, this podcast offers valuable wisdom and support from Ginny Kochis, a compassionate and relatable Catholic mom.

Joining Eric today is the assistant Athletic Director, and Direct of Olympic Sports Strength and Conditioning at Clemson University.  He is also directly responsible for the strength and conditioning of the Clemson baseball team. Welcome to the show Rick Franzblau.PRODUCED BY:Lagos Creative

Video can be a crucial part of the sales process. People love stories. Video is a great way to share your service or product story. Chad Laken joins Donald today on how to utilize videos throughout sales process. Video is powerful Video can be daunting and somewhat intimidating. Using video in emailing a prospect adds a deeper touch. It takes 8-12 touchpoints. Video expands your ability to build trust. Individualize your video for a stronger impact. Your video is a great way to introduce you and your company to all decision-makers. Personalization at the top of the sales funnel. Create helpful content for your prospects Developing the business relationship with video will launch you further than the funnel. Rinse and repeat your bank of video content. Make a video answering commonly asked questions from your prospects. 95% of retention is increased when you use a video. Top use cases to utilize video Put context to your video to make a lastly impression Send a video when you are being ghosted by your prospect. Develop a journey map for your video content. Have fun! “Video is what makes great salespeople memorable.”– Chad Lakin Connect with Chad on LinkedIn or Shootsta This episode is brought to you in part by Skipio. Be more like people and start having conversations that end in the conversions you want. Try Skipio at www.Skipio.com. This episode is brought to you in part by Scratchpad. Scratchpad is the first Revenue Team Workspace specifically designed to adapt to each salesperson's workflow, so you don't have to change your habits. Get Scratchpad free at Scratchpad.com.  This episode is brought to you in part by LinkedIn.  The sales landscape is totally changing. You need to adapt to succeed. Deep Sales, a part of the next generation of LinkedIn Sales Navigator, can help you do just that. Check it out yourself and get a 60-day free trial at Linkedin.com/TSE. This episode is brought to you in part by Calendly. The power of scheduling automation has never been more critical than it is today. Your sales team needs a solution to easily meet with prospects at the right time, every time. Finish the year strong and request a demo of Calendly today at Calendly.com/TSE.  Credits As one of our podcast listeners, we value your opinion and always want to improve the quality of our show. Complete our two-minute survey here: thesalesevangelist.com/survey. We'd love for you to join us for our next episodes by tuning in on Apple Podcast, Google Podcast, Stitcher, or Spotify.  Audio is provided by Free SFX, Soundstripe, and Bensound. Other songs used in the episodes are The Organ Grinder written by Bradley Jay Hill, performed by Bright Seed, and Produced by Brightseed and Hill.

Video can be a crucial part of the sales process. People love stories. Video is a great way to share your service or products story. Chad Laken joins Donald today on how to utilize videos throughout the whole sales process. Video is powerful Video can be daunting and somewhat intimidating. Using video in emailing a prospect adds a deeper touch. It takes 8-12 touchpoints. Video expands your ability to build trust. Individualize your video for a stronger impact. Your video is a great way to introduce you and your company to all decision makers. Personalization at the top of the sales funnel. Create helpful content for your prospects Developing the business relationship with video will launch you further than the funnel. Rinse and repeat your bank of video content. Make a video answering commonly asked questions from your prospects. 95% of retention is increased when you use a video. Top use cases to utilize video Put context to your video to make a lastly impression Send a video when you are being ghosted by your prospect. Develop a journey map for your video content. Have fun! “Video is what makes great salespeople memorable.”– Chad Lakin Connect with Chad on LinkedIn or Shootsta This episode is brought to you in part by Skipio. Be more like people and start having conversations that end in the conversions you want. Try Skipio at www.Skipio.com. This episode is brought to you in part by Scratchpad. Scratchpad is the first Revenue Team Workspace specifically designed to adapt to each salesperson's workflow, so you don't have to change your habits. Get Scratchpad free at Scratchpad.com.  LinkedIn  The sales landscape is totally changing. You need to adapt to succeed. Deep Sales, a part of the next generation of LinkedIn Sales Navigator, can help you do just that. Check it out yourself and get a 60-day free trial at Linkedin.com/TSE. Calendly The power of scheduling automation has never been more critical than it is today. Your sales team needs a solution to easily meet with prospects at the right time, every time. Finish the year strong and request a demo of Calendly today at Calendly.com/TSE.  Credits As one of our podcast listeners, we value your opinion and always want to improve the quality of our show. Complete our two-minute survey here: thesalesevangelist.com/survey. We'd love for you to join us for our next episodes by tuning in on Apple Podcast, Google Podcast, Stitcher, or Spotify.  Audio is provided by Free SFX, Soundstripe, and Bensound. Other songs used in the episodes are The Organ Grinder written by Bradley Jay Hill, performed by Bright Seed, and Produced by Brightseed and Hill.